ARWAN Pharmaceutical

Arwan Pharmaceutical Industries Lebanon s.a.l. is a joint-stock company owned by a group of highly dedicated Lebanese and non-Lebanese professionals. The company commenced operations of its first sterile injectable production unit in 2013. Arwan develops, manufactures, and markets critical care products, focusing on next-generation anti-infectives, hematology, anesthetics and analgesics, gastrointestinal, oncology, bronchodilators, cardiovascular, osteoporosis, and wound management solutions.